Disease activity in inflammatory bowel disease patients is associated with increased liver fat content and liver fibrosis during follow-up.
Emilie E van LingenM E TushuizenM E J SteenhuisT van DeynenJ MartensD Diaz-Infante MoralesA E van der Meulen-de JongI MolendijkS van der MarelP W J MaljaarsPublished in: International journal of colorectal disease (2021)
This study confirms the relatively high prevalence of liver steatosis and fibrosis in IBD patients. We demonstrate that active IBD at baseline is associated with both an increase in liver steatosis and fibrosis during follow-up.
Keyphrases
- end stage renal disease
- liver fibrosis
- disease activity
- rheumatoid arthritis
- newly diagnosed
- chronic kidney disease
- systemic lupus erythematosus
- prognostic factors
- insulin resistance
- high fat diet
- patient reported outcomes
- ankylosing spondylitis
- metabolic syndrome
- rheumatoid arthritis patients
- fatty acid
- juvenile idiopathic arthritis
- patient reported